Since 1999, Prof Guy Rostoker has been the Medical Director of the Division of Nephrology and Dialysis at the Claude Galien Private Hospital (Ramsay Health Care France ) at Quincy sous Sénart, France. He completed a doctorate in fundamental immunology at Paris VII University, France, in 1992. He held the position of Chief-Resident in Division of Nephrology at Henri Mondor University Hospital (1987-1991) and the position of Assistant Professor of Nephrology (1991-1996). In 2017, he was appointed Associate Professor at Collège de Médecine des Hôpitaux de Paris and in 2022, Professor (with tenure). He was scientific counsellor of the French Committee for Drugs Reimbrusement at the French High Health Care Authority (HAS, 2009-2012) and a full member (with tenure) of this committee (2013-2018). He has published 160 papers in various journals indexed in PubMed and serves a role in French, European, and American renal Societies. His interests in research projects include nephrology, dialysis, COVID 19 in the setting of ESKD, and iron metabolism and toxicity of iron pharmaceutical products
Since 1999, Prof Guy Rostoker has been the Medical Director of the Division of Nephrology and Dialysis at the Claude Galien Private Hospital (Ramsay Health Care France ) at Quincy sous Sénart, France. He completed a doctorate in fundamental immunology at Paris VII University, France, in 1992. He held the position of Chief-Resident in Division of Nephrology at Henri Mondor University Hospital (1987-1991) and the position of Assistant Professor of Nephrology (1991-1996). In 2017, he was appointed Associate Professor at Collège de Médecine des Hôpitaux de Paris and in 2022, Professor (with tenure). He was scientific counsellor of the French Committee for Drugs Reimbrusement at the French High Health Care Authority (HAS, 2009-2012) and a full member (with tenure) of this committee (2013-2018). He has published 160 papers in various journals indexed in PubMed and serves a role in French, European, and American renal Societies. His interests in research projects include nephrology, dialysis, COVID 19 in the setting of ESKD, and iron metabolism and toxicity of iron pharmaceutical products